FORA Capital LLC Takes Position in Option Care Health, Inc. (NASDAQ:OPCH)

FORA Capital LLC acquired a new stake in Option Care Health, Inc. (NASDAQ:OPCH) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 37,630 shares of the company’s stock, valued at approximately $1,178,000.

Other large investors also recently made changes to their positions in the company. UMB Bank n.a. boosted its holdings in shares of Option Care Health by 937.5% in the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after buying an additional 750 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after buying an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. boosted its holdings in shares of Option Care Health by 3,362.8% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after buying an additional 1,446 shares during the last quarter. Blue Trust Inc. boosted its holdings in shares of Option Care Health by 14.8% in the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after buying an additional 377 shares during the last quarter. Finally, International Assets Investment Management LLC boosted its holdings in shares of Option Care Health by 3,029.7% in the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after buying an additional 2,757 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Stock Up 0.1 %

OPCH stock opened at $23.76 on Thursday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The stock has a market capitalization of $4.04 billion, a price-to-earnings ratio of 19.97, a PEG ratio of 2.42 and a beta of 1.32. The business’s fifty day moving average price is $27.16 and its two-hundred day moving average price is $28.96. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $34.63.

Insiders Place Their Bets

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The shares were bought at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the transaction, the director now owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 0.64% of the company’s stock.

Analyst Ratings Changes

OPCH has been the topic of a number of research analyst reports. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Barrington Research dropped their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research note on Thursday, October 31st. Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th. Truist Financial dropped their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Finally, JMP Securities increased their price target on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, Option Care Health presently has a consensus rating of “Moderate Buy” and an average price target of $30.83.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.